Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
Friday, AbbVie Inc (NYSE:ABBV) reported first-quarter adjusted EPS of $2.31, down 6.1% Y/Y, beating the consensus of $2.23.Net revenues reached $12.31 billion, up 0.7%, beating the consensus of $11.92
BenzingaApr 26 09:54 ET
Stockholder Alert: Ademi LLP Continues Investigation of the Fairness of Landos Biopharma, Inc.'s Transaction With AbbVie
MILWAUKEE, April 16, 2024 /PRNewswire/ -- Ademi LLP investigation of Landos (NASDAQ: LABP) continues now that Landos has filed a preliminary proxy statement seeking stockholder approval for its trans
PR NewswireApr 16 15:32 ET
The latest information on major US company ratings published on 04/01 (Monday): RIOT, PFC, DOC, TRU, etc.
The latest information on ratings of major US companies was announced on 04/01 (Monday).
moomooニュース米国株Apr 1 08:55 ET
Landos Biopharma Cut to Neutral From Buy by HC Wainwright & Co.
Landos Biopharma Cut to Neutral From Buy by HC Wainwright & Co.
Dow JonesApr 1 07:22 ET
Express News | HC Wainwright & Co. Downgrades Landos Biopharma to Neutral, Lowers Price Target to $20.42
Moomoo 24/7Apr 1 07:12 ET
Landos Biopharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 -4.67% HC Wainwright & Co. $50 → $20.42 Downgrades Buy → Neutral 01/06/2023 -99.53% Jefferies $
BenzingaApr 1 07:04 ET
Maintaining Hold Rating on Landos Biopharma Amid Acquisition by AbbVie and Limited Upside Potential
TipRanksApr 1 06:17 ET
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Yahoo FinanceMar 28 09:50 ET
Leerink Partners Remains a Hold on Landos Biopharma (LABP)
TipRanksMar 27 02:57 ET
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
Yahoo FinanceMar 26 10:03 ET
Sector Update: Health Care Stocks Softer in Afternoon Trading
Health care stocks were easing Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.2%. The iShares Biotechnology ETF (IBB) decreas
MT NewswiresMar 25 14:01 ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Landos Biopharma, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - March 25, 2024) - Rigrodsky Law, P.A. is investigating Landos Biopharma, Inc. ("Landos") (NASDAQ: LABP) regarding possible breaches of fiduciary duties and othe
newsfileMar 25 13:49 ET
Landos (LABP) Secures AbbVie Deal: Propelling Novel Oral Therapy Development
The current surge of Landos Biopharma, Inc. (NASDAQ: LABP) shares on the US charts, marking a notable surge of 168.27% to $21.46 per share as of the last check, is attributed to a takeover bid. Today, Landos (LABP) disclosed a definitive agreement with AbbVie Inc., outlining AbbVie's intent to acquire Landos. At the forefront of ...
Stocks TelegraphMar 25 13:09 ET
NIMML Institute's TITAN-X A.I.-Powered Precision Medicine Platform Validated Through AbbVie's Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13
NIMML founders Dr. Bassaganya-Riera, Dr. Hontecillas, and scientific director Dr. Leber discovered, characterized, and led the development of NX-13 from discovery to successful clinical testing in Ulcerative Colitis
BusinesswireMar 25 12:40 ET
Shareholder Alert: Ademi LLP Investigates Whether Landos Biopharma, Inc. Has Obtained a Fair Price in Its Transaction With AbbVie
MILWAUKEE, March 25, 2024 /PRNewswire/ -- Ademi LLP is investigating Landos (NASDAQ: LABP) for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie. Click he
PR NewswireMar 25 12:03 ET
Crude Oil Moves Higher; US New Home Sales Fall In February
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The S
BenzingaMar 25 11:54 ET
Express News | Landos Biopharma Shares Are Trading Higher After the Company Announced That It Entered Into a Definitive Agreement to Be Acquired by AbbVie
Moomoo 24/7Mar 25 10:54 ET
US Stocks Down; Chicago Fed National Activity Index Rises In February
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market opening Monday, the Dow traded down 0.16% to 39,412.36 while the NASDAQ fell
BenzingaMar 25 09:42 ET
Landos Biopharma Shares Surge 178% on Takeover Deal With AbbVie
By Sabela Ojea Shares of Landos Biopharma on Monday surged 178% to $21.75 in pre-market trading after the company said it signed a deal to be acquired by AbbVie. The companies have reached a definit
WSJMar 25 09:28 ET
Landos Biopharma's Definitive Merger With AbbVie Subsidiary
TipRanksMar 25 09:13 ET
No Data
No Data